Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Care | Research

Potentially preventable hospitalizations and super-utilization of inpatient services among patients with chronic kidney disease in Hawaiʻi

Authors: Devashri Prabhudesai, James Davis, John J. Chen, Eunjung Lim

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

Chronic kidney disease (CKD) is linked to high morbidity and mortality and increased hospitalization burden. If appropriately managed in the outpatient setting, ambulatory care-sensitive conditions (ACSCs) do not lead to hospitalization. Hospitalizations due to ACSCs are considered as potentially preventable hospitalizations. Patients with recurrent hospitalizations are considered as super-utilizers of inpatient services. The aim of this study is to determine prevalence of potentially preventable hospitalizations and super-utilization of inpatient services among patients with CKD in Hawaiʻi.

Methods

Hawaiʻi statewide inpatient data (2015–2017) were used to identify adult CKD patients with hospitalizations during a 12-month period from the first recorded date of CKD. The associations between the potentially preventable hospitalizations and super-utilization and other key patient demographic and clinical variables (sex, age, ethnicity, insurance type, Charlson comorbidity index (CCI), county of residence, and homelessness indicator) were analyzed using bivariate analysis. Multivariable logistic regression was utilized to assess the associations between the potentially preventable hospitalizations and patient variables.

Results

Approximately 2% of patients reported potentially preventable hospitalizations, and a total of 12.3% patients reported super-utilization. Out of all CKD-specific ACSC hospitalizations, 74.2% were due to heart failure and 25.8% were due to hyperkalemia. Patients who reported super-utilization were more likely to report potentially preventable hospitalization (OR: 5.98, 95%CI: 4.50–7.93) than patients who did not report super-utilization.

Conclusion

This study showed prevalence of potentially preventable hospitalizations and high inpatient utilization among CKD patients in Hawaiʻi. Heart failure and hyperkalemia were the two major causes of CKD-specific ACSC hospitalizations in this cohort. Effective strategies should be employed to improve the outpatient CKD management to reduce hospitalizations and in turn reduce cost.
Literature
4.
go back to reference GBD chronic kidney disease collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–33.CrossRef GBD chronic kidney disease collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–33.CrossRef
10.
go back to reference Sentell TL, Seto TB, Quensell ML, Malabed JM, Guo M, Vawer MD, et al. Insights in public health: outpatient care gaps for patients hospitalized with ambulatory care sensitive conditions in Hawai'i: beyond access and continuity of care. Hawaii J Health Soc Welf. 2020;79(3):91–7. Sentell TL, Seto TB, Quensell ML, Malabed JM, Guo M, Vawer MD, et al. Insights in public health: outpatient care gaps for patients hospitalized with ambulatory care sensitive conditions in Hawai'i: beyond access and continuity of care. Hawaii J Health Soc Welf. 2020;79(3):91–7.
22.
Metadata
Title
Potentially preventable hospitalizations and super-utilization of inpatient services among patients with chronic kidney disease in Hawaiʻi
Authors
Devashri Prabhudesai
James Davis
John J. Chen
Eunjung Lim
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-03048-3

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.